ABG Intellectual Property

Founded in 2003, ABG Intellectual Property is one of the leading Spanish IP firms. Our team includes 22 European Patent Attorneys,12 Spanish Patent & Trademark Agents, 6 European Trademark & Design Attorneys, and 5 Attorneys-at-law. They advise clients ranging from individual investors, small companies and startups, universities and research institutions to big multinational corporations on patents, trademarks, designs, plant varieties and associated aspects of IP.

Alcura Health

Asphalion

ASPHALION is an international Regulatory, Scientific & Safety consultancy company with offices in Barcelona, Madrid, Munich, London, and Pamplona. Since its foundation in 2000, ASPHALION has grown consistently to employ over 190 professionals representing more than 16 nationalities. Its strong track record has established ASPHALION as a key player in the international healthcare sector and a major contributor to the implementation of new regulatory standards.
ASPHALION provides expert consulting, strategic advice, operational support, and full outsourcing services for all product life cycle stages across all therapeutic areas. Its team offers tailored solutions for Pharmaceutical, Biotechnological, and Medical Technology companies, having successfully delivered over 5,000 projects for more than 1,000 clients from over 50 countries. Services span non-clinical and clinical development, CMC, dossier writing, regulatory procedures, vigilance, eSubmissions, and data management for both medicinal products and medical devices.
The company’s expertise is particularly notable in the field of Advanced Therapy Medicinal Products (ATMPs), where their team possesses specialized scientific knowledge and extensive regulatory experience. ATMPs require unique development strategies and regulatory adaptations due to their complexity. ASPHALION provides comprehensive support, including drafting regulatory, non-clinical, clinical, and CMC documentation essential for development, registration, and lifecycle management. Additionally, they offer strategic guidance on segmentation, niche indications, conditional approvals, fast-track processes, orphan drug designations, and preclinical and clinical development plans to minimize time-to-market.
ASPHALION has been a leader in ATMP regulatory support since 2005, participating in over 30 projects covering cell therapy (autologous and allogenic derived stem cells, CAR-T) and gene therapy (oncolytic viruses, adeno-associated virus (AAV), Modified Vaccinia Virus (MVA), Plasmids, Lentivirus, Adenovirus (AdV), and more). By collaborating closely with international competent authorities, notified bodies, scientific associations, and key opinion leaders, ASPHALION ensures the delivery of optimal solutions for every project. Their comprehensive network of geographic and functional partners further solidifies their ability to meet the needs of a dynamic and evolving healthcare landscape.

Carbogen Amcis

CARBOGEN AMCIS provides drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) - as well as drug products for preclinical studies, clinical trials and commercial use. Besides being a service provider we also offer high quality Cholesterol and Vitamin D analog products produced at our facility in The Netherlands.

We forge close collaboration and open communication with our customers which ensures we work effectively as a team, meeting (if not exceeding) our customers' expectations. We aim to manufacture pharmaceutical ingredients at the highest standard of GMP whilst protecting the environment.

We are a partner you can trust and we look forward to helping you move your project faster to the market!

Bexen Bioservices

Biorepositorio Iberia

Solución integral en la gestión y almacenamiento de muestras biológicas y fármacos termolábiles en instalaciones diseñadas con máximas de seguridad, trazabilidad y redundancia

Cellab CDMO

Cellab CDMO is a Contract Development and Manufacturing Organization (CDMO) specialized in cell and gene therapy.

Our team has a decade of expertise in ATMP manufacturing and GMP processes, we specialize in collaborating closely with small teams to advance ATMPs from basic research to early clinical trials.

We partner closely with our clients, acting as an extension of their team to accelerate the journey from bench to bedside. Our agile approach allows us to adapt quickly to evolving project needs, ensuring timely delivery and success.

Cocoon Bioscience

Cocoon es una empresa biotecnológica dedicada a la producción de proteínas recombinantes utilizando como sistema de expresión crisálidas que actúan como biorreactores naturales.

La misión de Cocoon es producir proteínas complejas o difíciles de expresar a costes reducidos y así poder aliviar algunos de los problemas derivados de la cadena de aprovisionamiento.
Nuestro portafolio incluye enzimas y factores de crecimiento recombinantes para la industria biotecnológica (enzimas para expresion mRNA y secuanciación génica) y de carne cultivada (factores de crecimiento).

Charles River

Supporting the full drug discovery
and development continuum.
No matter where you are in your drug development journey, we can provide you with a wide range of products, models, services and guidance that are tailored to your specific needs:
- Basic Research
- Discovery
- Preclinical Testing
- Clinical Development
- Manufacturing and Commerzialisation
- Scientific and Regulatory Guidance

CMG MedDev

CMG MedDev is a dedicated consulting services wit more than 30 years of experience with focus on the field of medical devices, in vitro diagnostics, CDx, software and AI. We offer a tailor made solutions in Regulatory, Quality and Clinical services. CE mark submissions and FDA pre- submissions & submissions.

CSIC

CSIC (Spanish National Research Council) is the largest public research organization in Spain and the third largest in Europe. Our research is the basis of our contribution to society via dissemination, training, and transfer of knowledge and technology. We offer a wide range of technologies in pharmaceuticals, diagnostics, biomaterials and medical devices. We are open to different collaborative approaches, including opportunities for investment.

Curapath

Curapath is a CDMO specializing in novel drug delivery systems (DDS) with expertise in LNP and PNP formulation and GMP manufacturing. We support the entire therapeutic journey, from development to Commercial, providing GMP manufacturing for Drug Substance and Drug Product. With unmatched technical and analytical expertise, we design, develop, and manufacture polymer- and lipid-based DDS for cell therapy, gene therapy, and vaccines. For over a decade, we’ve supported innovators with excipients, polymers, and linkers, accelerating drug development with hands-on guidance and scalable solutions

Danagen Bioted

Evidentiq

EvidentIQ is a leading provider of innovative clinical trial technology solutions, offering a comprehensive suite of tools designed to enhance the efficiency, accuracy, and compliance of clinical research. With a strong focus on data-driven decision-making, EvidentIQ empowers pharmaceutical, biotech, and medical research organizations with cutting-edge solutions in Electronic Data Capture (EDC), Clinical Data Management (CDM), eCOA, and Real-World Evidence (RWE).
By leveraging advanced analytics, artificial intelligence, and a user-centric approach, EvidentIQ streamlines clinical trial processes, ensuring regulatory compliance and accelerating drug development. Committed to driving innovation in life sciences, EvidentIQ partners with research teams worldwide to deliver high-quality, patient-centric outcomes.

GEA

GEA es uno de los mayores proveedores mundiales de sistemas para los sectores alimentario, de bebidas y farmacéutico. Nuestra cartera incluye maquinaria y plantas, así como tecnología avanzada de procesos, componentes y servicios integrales. Utilizados en diversos sectores, mejoran la sostenibilidad y la eficiencia de los procesos de producción en todo el mundo.

GEA cotiza en el MDAX alemán y en el índice STOXX® Europe 600, y también se encuentra entre las empresas que componen los índices DAX 50 ESG y MSCI Global Sustainability.

Genscript

Gesfilter

Gesfilter was founded in 1995 with the mission to offer industry the best solution for the microfiltration of all types of fluids.

Our main objective is to collaborate with users to optimise their processes, proposing the most suitable solution for each application.

The experience accumulated over more than 25 years in various industrial sectors, together with our wide range of products, means that we can offer comprehensive and tailor-made solutions for every need in the clarification, microfiltration, stabilisation and/or sterilisation of liquids and gases.

Our vocation for continuous improvement in the quality of service to our customers has made it possible that since 2005 our main activity of design, development and commercialisation of filtration equipment for liquids and gases has been endorsed by the ISO 9001 Certification.

Histocell

i+Med

i+Med is a pharmaceutical company and the only scientist-led cooperative worldwide, dedicated to the development, manufacturing, and commercialization of injectables, ophthalmic drops, and topical products for the therapeutic areas of traumatology, aesthetics, ophthalmology, and oral health. It distributes its products under its own brand or private label in over 60 countries worldwide.

A global leader in smart hydrogel and nanohydrogel technologies, i+Med develops innovative formulas and products under its patented controlled-release technologies. The company is capable of executing the full value cycle of a medical device, from formulation to certification, bringing to market innovative products that enhance patients' quality of life.

IBEC

The Institute for Bioengineering of Catalonia (IBEC) conducts excellent interdisciplinary research at the frontiers of engineering and life sciences in order to generate new knowledge by putting together fields like nanomedicine, biophysics, biotechnology, tissue engineering and the applications of health information technology.

IBEC was established in 2005 by the Ministries of Innovation, Universities and Enterprises and Health of the Generalitat de Catalunya (Autonomous Government of Catalonia), the University of Barcelona (UB) and the Technical University of Catalonia (UPC). Today, IBEC’s relationship with the UB and UPC researchers continues to operate under a framework agreement signed in 2008.

The institute currently has 22 research groups and 318 researchers and staff from 37 different countries. The location of IBEC in the Parc Científic de Barcelona offers a highly stimulating biomedical environment in which the institute can work closely with organisations from the public and private sector interested in the biomedical application of nanotechnology.

IBEC is part of a new wave of research initiatives set up in the last decade, with shared interests and points of view concerning how to advance the frontiers of knowledge in experimental science to benefit clinical and biomedical research. The common denominator shared by these new initiatives is their focus on the enormous challenge of how to make life science quantitative on any scale, taking full advantage of the unprecedented power of the convergence between nano, bio and ICT.

The knowledge that exists in the IBEC research groups is structured in three broad avenues of knowledge: nanomedicine, cellular and tissue engineering and ICT for health. These are placed at the service of science and society to progress in three major application areas, namely: Bioengineering for Future Medicine, Bioengineering for Regenerative Therapies, Bioengineering for Active Ageing.

Idibe UMH

The Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE) of the Miguel Hernández University (UMH) develops an interdisciplinary preclinical R&D&I, basic and translational program in health biotechnology with the aim of providing solutions to current health challenges.

Our Mission : We generate knowledge and transform it into biotechnological solutions improving the welfare of our society.

Our Vision: To be a research center of excellence at the service of society, through the generation and transfer of knowledge, training and innovation.

IQS

IQS Tech Transfer is the division of IQS responsible for managing RDI and technology transfer activities, offering customized solutions to business needs. Using scientific and technical expertise along with cutting-edg techniques, IQS Tech Transfer drives technological advancement through research, technological development, and industrial innovation.

Kadans

Across Europe, we have built a network of leading researchers, entrepreneurs, partners and innovators, active in Life Sciences & Health, Agri & Food, Energy & Chemistry, and High Tech Systems & Materials. All determined to find solutions to the global challenges we face today. All determined to make a difference.

Therefore, we invest, develop and operate specialised assets to complement science clusters across Europe. These are not just standard workspaces. We create environments in which scientific organisations can thrive. Bespoke research facilities that are curated to suit your needs and support future growth.

Within each building and wider science cluster you will find organisations of all sizes, which can help you scale or support you as you need. Whether you need access to talent, research, or capital, you will find connections with the right people, in the right organisation.

Konexio Biotech

At Konexio Biotech, a consultancy specialized in regulatory affairs, we bridge biomedical research and the pharmaceutical industry to develop innovative products that shape the future of medicine.
Our team combines scientific expertise (advanced therapies, molecular biology, bioinformatics, omics sciences...) with deep knowledge of the pharmaceutical sector (quality, clinical trials, pharmacovigilance, market access...).
We offer a 360° service: from product design and regulatory strategy to staff training and market entry.

Labware Solutions

LabWare LIMS is a laboratory information management system (LIMS) that helps labs manage samples and data. It can automate workflows, integrate instruments, and track samples.
Features
-Centralized database: Stores samples, metadata, results, workflows, and instruments
-Compliance: Helps labs meet regulatory standards
-Data integrity: Enforces restricted access to authorized personnel
-Autosave: Automatically saves and records data changes in an audit trail
-Integration: Integrates with devices like barcode scanners and laboratory instruments
- Mobile access: LabWare MOBILE app is compatible with Android and iOS devices

Benefits
- Streamlines lab processes
- Reduces potential errors
- Ensures that all data changes are automatically saved and recorded
- Helps labs meet stringent regulatory requirements
- Maximizes efficiency
- Minimizes risks in production
- Provides visibility of data in real time
- On premise and SaaS Solutions

Leitat

Levprot Bioscience

Levprot Bioscience is a leader in recombinant protein production through precision fermentation, delivering high-quality, animal-free solutions for the biopharma and in vitro diagnostics (IVD) industries. Our portfolio includes recombinant enzymes, blocking buffers, and recombinant bovine serum albumin (rBSA), designed to enhance the performance and reliability of diagnostic assays. With a focus on sustainability, innovation, and precision, we provide tailored protein solutions to meet the specific needs of IVD and Foodtech manufacturers, ensuring consistency and quality in every batch.

MAI CDMO

MAI CDMO is a sotware development company that fosters a collaborative ecosystem within the pharmaceutical industry. We bridge the gap between pharmaceutical companies and CMO/CDMOs, ensuring optimal resource allocation throughout the development process. This collaborative approach empowers our partners to achieve their goals with greater efficiency and focus on what matters most: innovation.
https://mai-cdmo.com

Medina

MEDINA is a Research Organization focused on early stages of Drug Discovery established from the former Merck Research Labs in Spain, and reference center in Natural Products Research. We develop research collaborations with industrial and academic partners worldwide to support early discovery programs.

MEDINA´s team has solid industry experience in project management and unique expertise in small molecule discovery including:
• natural products chemistry and biosnthesis
• Molecular microbiology and natural product production, scale fermentation
• high throughput screening,
• cell biology,
• early ADME-Safety,
• analytical chemistry platform for bioanalysis
• metabolomics (natural products and patient samples)

MediTox

MediTox is a GLP-certified CRO with experience in variety of compounds and therapeutic areas, capable to conduct experiments and studies in full compliance with GLP standards and another international guidelines (EMA/ICH, VICH, OECD, FDA, ISO10993), providing core range of nonclinical studies supporting phases I - III of clinical trials and/or registration of human drugs, medical device and food additives and safety/BEQ/efficacy studies for registration of veterinary drugs and feed additives.

Summary of products/services
MediTox is a GLP-certified CRO having strong experience in
- MTD, DRF, pilot, proof-of-concept studies (rodents, non-rodents)
- Acute, sub-acute, subchronic, chronic toxicity studies (OECD, ICH/VICH, EFSA, rodents, - non-rodents)
- Medical device biocompatibility including implantation (ISO 10993, rodents, non-rodents)
- Genetic tox studies (OECD, ICH, ISO 10993. in vitro, in vivo)
- BA/BEQ/TK studies (OECD, ICHS, VICH, rodents, non-rodents)
- TAS, BEQ studies (VICH, dogs, cats, rabbits)
- Local effect (ICH, OECD, ISO 10993, Irritation, sensitization, local tolerance)
- Non-clinical safety, safety pharmacology (ICH)
- Medical device biocompatibility (ISO 10993, rodents, non-rodents)
- Feed and feed additives testing (EFSA, rodents, non-rodents)
- Experimental models available: chronic glaucoma (dog), arthritis (dog)

Meisys

Meisys is a scientific consultancy focused on giving integral solutions to companies of the healthcare sector, to become it’s major provider of medical and scientific knowledge. With services such as Medical Information, Pharmacovigilance, Medical Affairs, Medical Governance, Regulatory Affairs, Quality Assurance and Training, we have a multidisciplinary team with extensive experience in human and veterinary drugs, medical devices, cosmetics, and food supplements.

Mettler Toledo

METTLER TOLEDO is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences and biotech. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com

Multifiltra

En Multifiltra nos especializamos en la distribución de productos de alta calidad para la industria biofarmacéutica, ofreciendo soluciones integrales que abarcan desde materias primas hasta equipos especializados. Nuestro portafolio incluye materiales para la producción de medicamentos biológicos, anticuerpos monoclonales, vacunas y terapias génicas, garantizando el cumplimiento con los más estrictos estándares regulatorios.

Trabajamos con proveedores de confianza para asegurar que nuestros clientes cuenten con los recursos necesarios para optimizar sus procesos de fabricación, control de calidad y envasado. Con un enfoque en la innovación y el soporte técnico, apoyamos a las empresas biofarmacéuticas a llevar sus productos del laboratorio a la producción comercial de manera eficiente y segura.

Porton Pharmaceuticals

Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), and Advanced Therapy Medicinal Products from pre-clinical to commercialization stages. As of Dec. 31, 2024, we have a proven record for the delivery of more than 3500 projects and established cooperation with more than 1000 global clients. With our 4200 skilled employees working across 18 sites around the globe, Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world and enabling the public’s early access to good medicines.

Promega

Promega is a leading provider of high-quality reagents and instrumentation to the scientific community, dedicated to advancing progress in the life sciences. We pride ourselves on offering personalized customer service and specialized scientific advice tailored to the unique needs of each researcher.

Our extensive catalog features over 4,000 products that empower scientists worldwide to deepen their knowledge through research in key areas such as genomics, proteomics, cellular analysis, and drug discovery. Additionally, our products play a crucial role in specialized applications like molecular diagnostics and human identification, significantly contributing to advancements in health and safety.

Founded in 1978 in Madison, Wisconsin (USA), Promega Corporation, our parent company, was established with the mission of fostering an environment of innovation and creativity. Over the years, we have expanded our global presence, now operating proprietary offices in 15 countries and maintaining over 50 distribution agreements worldwide.

This year marks the 20th anniversary of our Spanish branch, Promega Biotech Ibérica S.L., which began its operations in Spain in 2005. For two decades, Promega Biotech Ibérica S.L. has been a trusted partner in the Iberian market, consistently delivering excellence and supporting the scientific community in Spain.

At Promega, we are committed to accompanying the scientific community every step of the way, providing tools and solutions that facilitate meaningful discoveries and promote global well-being.

Quimivita

Quimivita, acompañada de CG Chemikalien líder europeo en fabricación y suministro de ingredientes para la industria (Bio)Pharma, presenta su nueva línea de productos GMP. Destacan especialmente las soluciones Custom Made y PharmProve, de formulaciones personalizadas para procesos farmacéuticos y productos químicos de fabricación multi-compendial, cumpliendo estrictamente con las normas GMP.
Garantizamos una producción eficiente con ingredientes de alta pureza, formulaciones adaptadas y pleno cumplimiento normativo.

Robu

ROBU Glasfilter-Geräte GmbH – Precision Glass Filtration for Biotech & Life Sciences

ROBU is a leading manufacturer of high-quality sintered glass filters and precision glass components. Our Sinterpellets provide an advanced solution for cell culture applications, bioprocessing, and bioreactors, offering optimal porosity and chemical resistance. With decades of expertise in customized filtration solutions, we support biotech and life science industries with innovative, high-performance materials.

Selvita

Selvita is a preclinical CRO providing multidisciplinary support in resolving the unique challenges of research within the areas of drug discovery and drug development.

The company offers drug discovery support at every stage of the early discovery phase up to the preclinical development. Selvita specializes in a variety of drug discovery processes from in silico drug design and synthesis of a target-focused library, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro and in vivo pharmacology, structural biology, all tailored to the customer’s needs.

Selvita Group has broad expertise and track record in oncology, inflammation, fibrosis, anti-infectives, respiratory diseases and CNS.

Tecnalia

Vivotecnia

Vivotecnia is a fully independent European toxicology safety contract research organization (CRO) with headquarters based in Madrid, Spain.

We offer services to support preclinical product development for pharmaceutical and biotech companies

Our laboratories and different units are perfectly equipped and, working under Good Laboratory Practices. Our animal units house rodents, dogs, rabbits, minipigs and nonhuman primates, whose choice is justified by being the best candidates for different types of preclinical studies, thus minimizing the potential risks which might arise in the human species.

Working with Vivotecnia means working with a partner. Our highly qualified study management team, with lengthy experience in both pharmaceutical and CRO industries, fully understands the challenges you face and is committed to providing the knowledge, advice and high-quality service you expect.

We aim to ensure that you achieve your goals despite the magnitude of the challenges you face. Our innovative approach to study design ensures that your study is developed optimally, cost-effectively, ethically and in compliance with regulatory requirements

Xenopat

Xenopat is a CRO specialising in preclinical oncology services, providing researchers and companies with cutting-edge tools for the development of new cancer therapies. Our models and technologies support decision-making not only in preclinical phases, but also in clinical trials and even post-commercialisation.

We offer a wide range of models tailored to our customers' needs, from simpler systems such as cell-derived xenograft (CDX) and syngeneic models, to highly sophisticated models that closely mimic human biology and improve the success rate of cancer drug development. These include our extensive range of patient-derived xenograft (PDX) models and humanised murine models.

Beyond preclinical research, Xenopat also provides healthcare professionals and patients with advanced technology to support personalised treatment decisions. Our Orthoxenograft® (PDX) models, generated from a small fragment of a patient's tumour, allows us to test multiple therapies in a highly predictive system - helping to identify the most effective treatment for each individual.

Zendal